2016-09-01
Which cervical and endometrial cancer patients will benefit most from intensity-modulated proton therapy?
Publication
Publication
Radiotherapy & Oncology , Volume 120 - Issue 3 p. 397- 403
In this dosimetric comparison study it was shown that IMPT with robust planning reduces dose to surrounding organs in cervical and endometrial cancer treatment compared with IMRT. Especially for the para-aortic region, clinically relevant dose reductions were obtained for kidneys, spinal cord and bowel, justifying the use of proton therapy for this indication.
| Additional Metadata | |
|---|---|
| , , , , | |
| doi.org/10.1016/j.radonc.2016.06.016, hdl.handle.net/1765/93878 | |
| Radiotherapy & Oncology | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Sande, M.A.E. (Mariska) van de, Creutzberg, C., van de Water, S., Sharfo, A. W., & Hoogeman, M. (2016). Which cervical and endometrial cancer patients will benefit most from intensity-modulated proton therapy?. Radiotherapy & Oncology, 120(3), 397–403. doi:10.1016/j.radonc.2016.06.016 |
|